Development of tCAP(N3): Affinity Peptide‐Aided, pH‐Triggered Strategy for Site‐Specific Native IgG Modification

Direct modification of native antibodies with affinity peptides remains a significant challenge, primarily because the affinity peptide often stays bound to the antibody and blocks its interaction with key receptors. In this study, we developed tCAP(N3), a novel traceless chemical conjugation method that employs an affinity peptide. tCAP(N3) can be stored for over a year at refrigerated temperature, as it contains an active ester precursor that can be spontaneously activated under neutral conditions. When tCAP(N3) was mixed with a target native IgG, Ac-Lys(N<sub>3</sub>)-Gly-Gly was site-selectively transferred onto Lys248, yielding divalently azidated IgG that can be further modified with DBCO compounds. The resulting antibody conjugates retained Fc receptor binding and antigen recognition comparable to the parent IgG.

Authors

Institutions

Publication Details

Journal
Chemistry - A European Journal
Published
2025-12-24
DOI
https://doi.org/10.1002/chem.202503144
Citations
1
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
1.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of tCAP(N3): Affinity Peptide‐Aided, pH‐Triggered Strategy for Site‐Specific Native IgG Modification

Hiroko Kawakami, Yukie Nohara, Naoki Dozono, Abdur Rafique et al.
1 citations
Chemistry - A European Journal
Monoclonal and Polyclonal Antibodies Research
1.36
article

Development of tCAP(N3): Affinity Peptide‐Aided, pH‐Triggered Strategy for Site‐Specific Native IgG Modification

Hiroko Kawakami, Yukie Nohara, Naoki Dozono, Abdur Rafique, Masato Kiyoshi, Shun Masuda, Hiroko Shibata, Asaki Nagashima, Yuji Ito, Taku Yoshiya, Ken Sakamoto, Akiko Ishii‐Watabe, Shugo Tsuda
article en
1 citations

Abstract

Direct modification of native antibodies with affinity peptides remains a significant challenge, primarily because the affinity peptide often stays bound to the antibody and blocks its interaction with key receptors. In this study, we developed tCAP(N3), a novel traceless chemical conjugation method that employs an affinity peptide. tCAP(N3) can be stored for over a year at refrigerated temperature, as it contains an active ester precursor that can be spontaneously activated under neutral conditions. When tCAP(N3) was mixed with a target native IgG, Ac-Lys(N<sub>3</sub>)-Gly-Gly was site-selectively transferred onto Lys248, yielding divalently azidated IgG that can be further modified with DBCO compounds. The resulting antibody conjugates retained Fc receptor binding and antigen recognition comparable to the parent IgG.

Chemistry - A European JournalVol. 32(6)
Kagoshima University (JP), Peptide Institute (Japan) (JP), National Institute of Health Sciences (JP), Protein Research Foundation (JP), The University of Osaka (JP)
Japan Agency for Medical Research and Development
Openalex Percentile: Top 13%
Monoclonal and Polyclonal Antibodies Research
1.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development of tCAP(N3): Affinity Peptide‐Aided, pH‐Triggered Strategy for Site‐Specific Native IgG Modification — Hiroko Kawakami, Yukie Nohara, et al. · Chemistry - A European Journal (2025) | TGRS Research Map | TGRS